During the past decade, North Jersey Community Research Initiative conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Jersey Community Research Initiative" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 29 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Pharmacia" with 3 trials sponsored, "Glaxo Wellcome" with 2 trials sponsored and "Hoechst Marion Roussel" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Jersey Community Research Initiative" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Fujisawa Pharmaceutical Co" with 1 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator and "Jacobus Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "North Jersey Community Research Initiative" are "HIV Infections" (45 trials), "Mycobacterium Avium-intracellulare Infection" (4 trials), "Tuberculosis" (4 trials), "Pneumonia, Pneumocystis Carinii" (3 trials) and "Mycobacterium Avium-Intracellulare Infection" (2 trials). Many other conditions were trialed in "North Jersey Community Research Initiative" in a lesser frequency.

Most popular intervention types in "North Jersey Community Research Initiative" are "Drug" (35 trials), "Behavioral" (2 trials), "Device" (2 trials), "Dietary Supplement" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nelfinavir mesylate" (8 trials), "Didanosine" (6 trials), "Stavudine" (6 trials), "Indinavir sulfate" (5 trials) and "Lamivudine" (5 trials). Other intervention names were less common.

The vast majority of trials in "North Jersey Community Research Initiative" are 47 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "North Jersey Community Research Initiative". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 42 completed trials in North Jersey Community Research Initiative, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in North Jersey Community Research Initiative, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".